Skip to content

3Accepted Sep 24, 6:43 PM ET

LAV Biosciences Fund V, L.P. 3

ADRXADARx Pharmaceuticals, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

6:43 PM

Sep 24, 2026

Filed

Sep 24, 2026

Documents

1

Size

16.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.